| Aug 14 |
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
|
| Aug 13 |
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
|
| Aug 7 |
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
|
| Jul 26 |
Predictive Oncology looks to raise $1.3M through exercise of warrants
|
| Jul 26 |
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
|
| Jul 25 |
Why Predicitive Oncology Stock Is Soaring
|
| Jul 25 |
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
|
| Jun 11 |
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
|
| Jun 4 |
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
|
| May 29 |
Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
|
